Andere Kunden interessierten sich auch für
![Registration Process of Generic Budesonide DPI as per USFDA Guidelines]( "Registration Process of Generic Budesonide DPI as per USFDA Guidelines")
Registration Process of Generic Budesonide DPI as per USFDA Guidelines40,99 €![International Regulatory Approaches to Bioequivalence of Generic OIDPs]( "International Regulatory Approaches to Bioequivalence of Generic OIDPs")
International Regulatory Approaches to Bioequivalence of Generic OIDPs32,99 €![Regulatory Guidelines for Registration and Submission Criteria in South Africa (SAHPRA)]( "Regulatory Guidelines for Registration and Submission Criteria in South Africa (SAHPRA)")
Regulatory Guidelines for Registration and Submission Criteria in South Africa (SAHPRA)47,95 €![Drug Regulatory Affairs: Review]( "Drug Regulatory Affairs: Review")
Drug Regulatory Affairs: Review26,99 €![Clinical Trials: Comparative Study Of Guidelines In Europe and India]( "Clinical Trials: Comparative Study Of Guidelines In Europe and India")
Clinical Trials: Comparative Study Of Guidelines In Europe and India32,99 €![KAP of Pharmacist & Physician towards Generic Drug Use]( "KAP of Pharmacist & Physician towards Generic Drug Use")
KAP of Pharmacist & Physician towards Generic Drug Use26,99 €![Stability Indicating Assay Method For Bisacodyl as Per ICH Guidelines]( "Stability Indicating Assay Method For Bisacodyl as Per ICH Guidelines")
Stability Indicating Assay Method For Bisacodyl as Per ICH Guidelines39,99 €
Since drugs are so-called life-saving substances, the quality, safety, and efficacy of these substances pose a unique challenge for the manufacturers as well as regulators. The drug has to undergo several phases of screening by governmental agencies before it is being placed in the market. A country like India's skill mostly lies in developing low priced generic medicines. Our infrastructure and economy do not allow us to invest like the western countries. The quality of medicines produced in India is no way inferior to any of the medicines available globally. However irony of the situation is such that India produces the best quality medicine for the world, not for itself. This is primarily because of the reason that it does not have a standard for itself. All the countries in the world starting from highly regulated markets to less regulated market have a certain form of guidelines for registration of the drugs in their own territories. This current work proposes some guidelines those can be adapted by Indian Regulatory authorities so as to enhance the quality of pharmaceutical products in India to meet international standards.